Dupont Capital Management Corp Cytom X Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$6.33 - $9.91 $419,584 - $656,884	-66,285 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$6.6 - $9.0 $437,481 - $596,565	66,285 New	66,285 $512,000
Q4 2019 Jan 27, 2020	SELL	$5.17 - $8.91 $173,593 - $299,171	-33,577 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$7.38 - $12.25 $247,798 - $411,318	33,577 New	33,577 $248,000
Q4 2018 Feb 01, 2019	SELL	$12.69 - $18.61 $191,466 - $280,787	-15,088 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$21.38 - $29.68 $322,581 - $447,811	15,088 New	15,088 $345,000

123M

305K

121K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $213M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.